Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Philippe Jacques Wolgen Insider Profile
4 Followers
Philippe Jacques Wolgen, Chief Executive Officer & Managing Director at Clinuvel Pharmaceuticals Limited, holds 3.43M shares in Clinuvel Pharmaceuticals Limited (Ticker: CLVLF).
Philippe Jacques Wolgen Clinuvel Pharmaceuticals Limited (CLVLF)Chief Executive Officer & Managing Director
Clinuvel Pharmaceuticals Limited (CLVLF)
Chief Executive Officer & Managing Director
Ranked #12,875 out of 98,743 Corporate Insiders
Profitable Transactions
5 out of 8 Profitable Transactions
Average Return
+16.40%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Philippe Jacques Wolgen's holdings
Insider Roles
Chief Executive Officer & Managing Director
Roles that Philippe Jacques Wolgen holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Jul 05, 2021 - Jul 05, 2022
Return:+55.80%
The most profitable trade made by Philippe Jacques Wolgen
Philippe Jacques Wolgen's Trading History
List of latest transactions for each holding click on a transaction to see Philippe Jacques Wolgen's performance on stock
You May Also Like
Philippe Jacques Wolgen insider profile FAQ
What is the percentage of profitable transactions made by Philippe Jacques Wolgen?
The percentage of profitable transactions made by Philippe Jacques Wolgen is 63%.
What is the average return per transaction made by Philippe Jacques Wolgen?
The average return per transaction made by Philippe Jacques Wolgen is 16.40%.
What stocks does Philippe Jacques Wolgen hold?
Philippe Jacques Wolgen holds: CLVLF stocks.
What was Philippe Jacques Wolgen’s latest transaction?
Philippe Jacques Wolgen latest transaction was an Uninformative Buy of ―.
What was Philippe Jacques Wolgen's most profitable transaction?
Philippe Jacques Wolgen’s most profitable transaction was an Informative Sell of CLVLF stock on July 5, 2021. The return on the trade was 55.80%.
What is Philippe Jacques Wolgen's role in Clinuvel Pharmaceuticals Limited?
Philippe Jacques Wolgen's role in Clinuvel Pharmaceuticals Limited is Chief Executive Officer & Managing Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.